Considerations in pharmaceutical conversion: Focus on antihistamines

American Journal of Managed Care

Volumn 3, Issue 4, 1997, Pages 617-630

  Garbus, Stanley B ^a,f   Moulton, Benjamin W ^b   Meltzer, Eli O ^c   Reich, Paul R ^d   Weinreb, Linda F ^e   Friedman, Jay A ^f   Orland, Burton I ^f  

^a ClinMark Associates Inc   (United States)

^b American Society of Law Medicine and Ethics   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f NYLCare Health Plans ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; HISTAMINE H1 RECEPTOR ANTAGONIST;

ARTICLE; CAR DRIVING; CARDIOVASCULAR SYSTEM; DRUG COST; DRUG EFFECT; DRUG INTERACTION; DRUG USE; ECONOMICS; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MALPRACTICE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SATISFACTION; SLEEP STAGE; STANDARD; UNITED STATES;

AUTOMOBILE DRIVING; CARDIOVASCULAR SYSTEM; DRUG COSTS; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; DRUGS, GENERIC; HISTAMINE H1 ANTAGONISTS; HUMANS; LIABILITY, LEGAL; MALPRACTICE; MANAGED CARE PROGRAMS; PATIENT COMPLIANCE; PATIENT SATISFACTION; SLEEP STAGES; UNITED STATES;

EID: 0031114036     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Babe KS Jr, Serafin WE. Histamine, bradykinin, and their antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:582-600.
2. Larsen JS. Antihistamines: Structural classification, pharmacokinetics, and pharmacodynamics. In: Antihistamine Update Consensus Conference Proceedings Monograph. Sponsored by the University of Massachusetts Medical School Office of Continuing Education and Department of Family and Community Medicine. September 1994:14-16.
3. Olin BR, ed. Facts and Comparisons. St. Louis, MO: Facts and Comparisons, Inc; August 1993:188a-190a.
4. McEvoy GK, ed. AHSP 96 Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 1996:2-8, 12-15, 19-24, 28-33, 1734-1736.
5. Simons FER. H1-receptor antagonists: Clinical pharmacology and therapeutics. J Allergy Clin Immunol 1989;84: 845-861.
6. Simons FER, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 1994;330: 1663-1670.
7. Simons FER, Simons KJ. Pharmacokinetic optimization of histamine H1-receptor antagonist therapy. Clin Pharmacokinet 1991;21:372-393.
8. Simons FER, Simons KJ. H1-receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol. 1988;81:975-980.
9. Spencer CM, Faulds D, Peters DH. Cetirizine: A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-1080.
10. Haria M, Fitton A, Peters DH. Loratadine: A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994;48:617-637.
11. Meltzer EO. Comparative safety of H1 antihistamines. Ann Allergy 1991;67:625-633.
12. The Medical Letter® on Drugs and Therapeutics. Vol 38, No. 986. New Rochelle, NY: The Medical Letter; October 25, 1996.
13. Sorkin EM, Heel RC. Terfenadine: A review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29:34-56.
14. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269: 1532-1536.
15. Woosley RL, Darrow WR. Analysis of potential adverse drug reactions - A case of mistaken identity. Am J Cardiol 1994;74:208-209. Letter.
16. Ng PW, Chan WK, Chan TYK. Torsades de pointes during the concomitant use of terfenadine and cimetidine. Aust NZ J Med 1996;26:120-121.
17. Benton RE, Honig PK, Zamani K, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 1996;59:383-388.
18. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995;95: 1097-1110.
19. Nicholson AN, Pascoe PA, Turner C, et al. Sedation and histamine H1-receptor antagonism: Studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 1991;104:270-276.
20. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co; 1996:1295, 1537.
21. Roth T, Roehrs T, Koshorek G, et al. Sedative effects of antihistamines. J Allergy Clin Immunol 1987;80:94-98.
22. Dubuske L. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1995;74:345-354.
23. Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy. 1991;66:257-262.
24. O'Hanlon JF. Antihistamines and driving performance: the Netherlands. J Respiratory Diseases 1988;9(suppl 7A):S12-S17.
25. Offenloch K, Zahner G. Rated performance, cardiovascular and quantitative EEG parameters during simulated instrument flight under the effect of terfenadine. ArzneimittelForschung 1992;42:864-868.
26. Neves-Pinto RM, Lima GM, da Mota Teixeira R. A double-blind study of the effects of loratadine versus placebo on the performance of pilots. Am J Rhinology. 1992;6: 23-27.
27. US Department of Transportation Digest of State Alcohol-Highway Safety Related Legislation. 14th ed. Washington, DC: US Dept of Transportation; 1996.
28. Honig PK, Woosley RL, Zamani K, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-238.
29. Haverkamp W, Shenasa M, Borggrefe M, Breithardt G. Torsades de pointes. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: WB Saunders Co; 1995:885-899.
30. Allegra (fexofenadine HCl) Product Information. Hoechst Marion Roussel, Kansas City, MO. July 1996.
31. Brannan MD, Reidenberg P, Radwanski E, et al. Evaluation of pharmacokinetic and electrocardiographic parameters following 10 days of concomitant administration of loratadine with ketoconazole. J Clin Pharmacol 1994;34: 1009-1033.
32. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.
33. Kraft KE, Dore FH. Computerized drug interaction programs: How reliable? JAMA 1996;275:1087. Letter.
34. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996;275:1086. Letter.
35. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996;275:1339-1341.
36. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
37. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
38. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-423.
39. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 1993;71:251-258.
40. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 health status questionnaire. J Allergy Clin Immunol 1994;94:182-188.
41. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261;3273-3277.
42. Meichenbaum D, Turk DC. Facilitating Treatment Adherence. New York, NY: Plenum Press; 1987:41-184.
43. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
44. Harnish v Children's Hospital Medical Center. 387 [Mass 1982], 439 NE2d 240.
45. McCarthy RL. Ethics and the use of drug formularies. J Man Care Pharm 1996;2:76-82.
46. Glass RM. The patient-physician relationship: JAMA focuses on the center of medicine. JAMA 1996;275: 147-148. Editorial.
47. Wickline v State of California, 228 Cal Rptr 661, Court of Appeal No B01 0156 (1986).
48. Laine C, Davidoff F. Patient-centered medicine: a professional evolution. JAMA 1996;275:152-155.
49. Huggins v Long Drug Stores California, Inc. 24 Cal Rptr 2d 587, California Supreme Court No S030711-OP (1993).
50. Baraniuk JN, Meltzer EO, Spector SL. Chronic airway diseases: Reassessing the role of allergy. J Respiratory Diseases 1996;17(suppl 8A):S1-S56.
51. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994;73:35-39.
52. Ross RN. The costs of allergic rhinitis. Am J Man Care 1996;2:285-290.
53. Drug Topics Redbook. Montvale, NJ: Medical Economics Data; 1995, 1996.